Connect with us

Business

Why the CSL (ASX:CSL) share price is seesawing over the past month

Published

on

The CSL Limited (ASX: CSL) share price has been wobbling in recent times following the company’s ongoing plasma collection issues. Investors hit the sell button in February and March after digesting CSL’s half-year results announcement and experiencing a broader market slump thereafter.

While the global biotech’s shares have stabilised for now, the company is still facing headwinds.

At the time of writing, CSL shares are swapping hands for $271.38, up 0.16%.

What’s going on with CSL?

CSL has been in the spotlight receiving heavy media attention about its plasma stockpile, and AstraZeneca plc (NASDAQ: AZN) COVID-19 vaccine update.

First and foremost, CSL’s plasma collections have taken a hit over the past 14 months,…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Got money to invest for dividends? Here are 2 ASX shares on Tuesday 11 May 2021
Ethereum climbs even higher… but why? Dogecoin might be the answer